Skip to main content

Find Clinical Trials

Home
Conditions
Systemic Sclerosis

Clinical trial condition

Systemic Sclerosis

Explore clinical trials studying Systemic Sclerosis. Study availability and eligibility vary by location and protocol.

227 public trials 51 recruiting studies

Refine in advanced search Browse all conditions

Systemic Sclerosis trial results

Completed

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

NCT02396238

Conditions: Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +14 more
Locations: Arizona Arthritis and Rheumatology Research, PLLC Phoenix, Arizona, United States

Baptist Health Center for Clinical Research Little Rock, Arkansas, United States

Arthritis Associates of Southern California Los Angeles, California, United States

UCLA David Geffen School of Medicine Los Angeles, California, United States

View all 19 locations

View Trial Details

Completed

IL1-TRAP, Rilonacept, in Systemic Sclerosis

NCT01538719

Conditions: Connective Tissue Diseases, Diffuse Scleroderma, Diffuse Systemic Sclerosis, +6 more
Locations: Boston University Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis

NCT00555581

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Hospital for Special Surgery New York, United States

View Trial Details

Completed

ADMSCs for the Treatment of Systemic Sclerosis

NCT02975960

Conditions: Connective Tissue Diseases, Gangrene, Necrosis, +7 more
Locations: Seoul St. Mary's hospital Seoul, South Korea

View Trial Details

Completed

Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic Sclerosis

NCT01488214

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Caen University Hospital Caen, Calvados, France

Lille University hosiptal Lille, Nord, France

Rouen University hospital Rouen, Seine-Maritime, France

Amiens Launay Amiens, Sommes, France

View Trial Details

Completed

Nilotinib in the Treatment of Systemic Sclerosis

NCT01166139

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Hospital for Special Surgery New York, United States

View Trial Details

Completed

Itch and Clinacal Caracteristics in Systemic Sclerosis

NCT03297580

Conditions: Connective Tissue Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, +6 more
Locations: CHRU de Brest Brest, France

View Trial Details

Completed

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

NCT01042158

Conditions: Cardiovascular Diseases, Connective Tissue Disease, Connective Tissue Diseases, +12 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Psychological Treatments for Scleroderma

NCT00007267

Conditions: Behavior, Behavioral Symptoms, Connective Tissue Diseases, +11 more
Locations: Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis

NCT02105818

Conditions: Adherence to Medication Regime, Behavior, Connective Tissue Diseases, +16 more
Locations: Reha Rheinfelden Rheinfelden, Canton of Aargau, Switzerland

View Trial Details